Tharimmune, Inc. — Director's Dealing 2025

Aug 22, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-04-28

Reporting Person: Kahler Thomas Clay (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.33	2035-08-04	Common Stock (50000)		Direct

Footnotes

F1: 25,000 of the options vest on date of grant and 25,000 vest on August 4, 2026.